Your browser is no longer supported. Please, upgrade your browser.
Settings
ATNF [NASD]
180 Life Sciences Corp.
Index- P/E- EPS (ttm)-1.97 Insider Own17.50% Shs Outstand25.92M Perf Week-17.94%
Market Cap220.58M Forward P/E- EPS next Y- Insider Trans-3.42% Shs Float13.80M Perf Month7.31%
Income-9.30M PEG- EPS next Q- Inst Own7.20% Short Float21.97% Perf Quarter57.88%
Sales- P/S- EPS this Y-130.90% Inst Trans9.96% Short Ratio1.06 Perf Half Y8.55%
Book/sh0.91 P/B9.35 EPS next Y- ROA-76.60% Target Price- Perf Year-19.11%
Cash/sh0.02 P/C441.16 EPS next 5Y- ROE-156.80% 52W Range1.90 - 13.05 Perf YTD211.72%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-34.77% Beta-0.39
Dividend %- Quick Ratio0.10 Sales past 5Y- Gross Margin- 52W Low347.89% ATR1.12
Employees2 Current Ratio0.10 Sales Q/Q- Oper. Margin- RSI (14)48.52 Volatility8.63% 14.70%
OptionableYes Debt/Eq0.55 EPS Q/Q- Profit Margin- Rel Volume0.16 Prev Close8.51
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume2.86M Price8.51
Recom- SMA20-11.31% SMA5017.14% SMA20018.63% Volume446,442 Change0.00%
Apr-20-21 08:00AM  
Apr-19-21 05:00PM  
Apr-14-21 08:15AM  
Mar-26-21 08:30AM  
Mar-25-21 08:30AM  
Mar-24-21 08:30AM  
Mar-08-21 01:30PM  
Feb-24-21 04:00PM  
Feb-19-21 09:00AM  
Feb-17-21 12:00AM  
Jan-11-21 08:00AM  
Jan-05-21 02:50PM  
Dec-03-20 11:08AM  
Nov-24-20 10:00AM  
Nov-23-20 08:30AM  
Nov-17-20 08:00AM  
Nov-10-20 11:46AM  
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of drug candidates in the areas of inflammatory diseases, fibrosis, and pain. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and Anti-TNF platform, which focuses on fibrosis and anti-tumor necrosis factors; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company is headquartered in Menlo Park, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KRAUSS MARLENE10% OwnerDec 17Sale2.4816,50640,8802,006,858Dec 17 05:29 PM
KRAUSS MARLENE10% OwnerDec 15Sale2.4017,87742,9052,543,676Dec 17 05:29 PM
KRAUSS MARLENE10% OwnerDec 14Sale2.4510,00024,5002,561,553Dec 17 05:29 PM
KRAUSS MARLENE10% OwnerNov 25Sale2.7812,18233,8092,571,556Dec 01 07:00 PM
KRAUSS MARLENE10% OwnerNov 23Sale3.2660,633197,6762,583,738Dec 01 07:00 PM
KRAUSS MARLENE10% OwnerNov 19Sale2.1233,44570,8372,644,371Dec 01 07:00 PM
KRAUSS MARLENE10% OwnerNov 18Sale2.316,70015,4802,677,816Dec 01 07:00 PM
KRAUSS MARLENE10% OwnerNov 17Sale2.263,3007,4452,684,516Dec 01 07:00 PM